Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Marci D CottinghamJill A Fisher

Abstract

As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pose unknown risks to research subjects. Unlike sick participants seeking a therapeutic benefit, the motivations and barriers for healthy volunteers are more complex and understudied. Drawing on interviews and clinical trial data from 178 healthy volunteers, we examine how they perceive HIV/AIDS studies in the early stages of testing. A subset of healthy volunteers see phase I HIV/AIDS studies as particularly risky for reasons ranging from fear of catching the disease or having long-lasting and uncomfortable side effects to inexplicable fears that they cannot even articulate. Some participants have had past negative experiences in such trials that inform these views, but others cite information from staff and other participants as influential. Healthy volunteers' general fears concerning AIDS also shape their views of participating in phase I HIV/AIDS clinical trials.

References

May 20, 1998·European Journal of Clinical Pharmacology·M SibilleD V Durand
Dec 22, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·A R SheonP Fast
Aug 5, 2000·Phytotherapy Research : PTR·C CalabreseL J Standish
Aug 3, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Darawan ThapintaUNKNOWN Thai AIDS Vaccine Evaluation Group
Feb 20, 2004·Journal of Clinical Pharmacology·Walter K KraftScott A Waldman
Jul 12, 2005·The Journal of Clinical Investigation·Christine Grady
Dec 27, 2005·The Lancet Infectious Diseases·Edward MillsCurtis Cooper
Jul 5, 2006·British Journal of Clinical Pharmacology·Michel SibilleEmmanuel Krupka
Jun 9, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Magdalena E SobieszczykBeryl A Koblin
Oct 28, 2009·Antiviral Research·Trevor Hawkins
Oct 25, 2011·American Journal of Public Health·Jill A Fisher, Corey A Kalbaugh
Jan 11, 2012·Nature Biotechnology·Malorye Allison
Jun 15, 2012·AIDS Patient Care and STDs·Maria Constanza LuceroUNKNOWN Risvac-02 Study
Jun 6, 2013·AIDS and Behavior·Shayesta Dhalla, Gary Poole
Jul 23, 2013·Clinical Trials : Journal of the Society for Clinical Trials·Eric G DevineDomenic A Ciraulo
Nov 30, 2013·Clinical Trials : Journal of the Society for Clinical Trials·Neal W Dickert
Jan 23, 2014·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Rebecca Dresser
Feb 5, 2015·Vaccine·UNKNOWN VISR Working Group of Global HIV Vaccine EnterpriseMary Allen
Mar 6, 2015·Journal of Empirical Research on Human Research Ethics : JERHRE·Heather B Edelblute, Jill A Fisher
Jun 28, 2015·BMJ : British Medical Journal·Ezekiel J EmanuelDavid Wendler
Sep 10, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Rebecca A JohnsonDavid Wendler
Feb 10, 2016·BMJ : British Medical Journal·Nigel Hawkes
Sep 5, 2017·Social Psychology Quarterly·Marci D Cottingham, Jill A Fisher

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved